In a patient taking azathioprine who develops acute cystitis with hematuria, should the azathioprine be held and what is the appropriate treatment?

Azathioprine and Acute Cystitis with Hematuria

In a patient taking azathioprine who develops acute cystitis with hematuria, do not routinely discontinue azathioprine unless there is evidence of significant bone marrow suppression (neutrophil count <1.0 × 10⁹/L or platelet count <50 × 10⁹/L), and treat the cystitis according to standard guidelines with nitrofurantoin or trimethoprim-sulfamethoxazole as first-line agents.

Management Algorithm

Step 1: Assess Severity and Check Blood Counts Immediately

• Obtain urgent CBC with differential to evaluate for azathioprine-induced myelosuppression
• Check liver function tests as hepatotoxicity can occur with azathioprine 1
• Assess hemodynamic stability and severity of hematuria

The critical decision point is whether the hematuria represents:

1. Simple infectious cystitis (most common)
2. Azathioprine-induced bone marrow suppression with secondary bleeding
3. Azathioprine hypersensitivity syndrome (rare but serious)

Step 2: Decision on Azathioprine Continuation

Continue azathioprine if:

• Neutrophil count ≥1.0 × 10⁹/L
• Platelet count ≥50 × 10⁹/L
• No signs of hypersensitivity (fever, rash, systemic symptoms)
• Hematuria is mild and attributed to infection

Immediately discontinue azathioprine if:

• Neutrophil count <1.0 × 10⁹/L 1, 2
• Platelet count <50 × 10⁹/L 1
• Signs of azathioprine hypersensitivity syndrome (fever with chills, systemic erythema, acute inflammatory response) 3
• Severe or life-threatening bleeding

Reduce azathioprine dose if:

• Lymphocyte count <0.5 × 10⁹/L 1
• Downward trend in blood counts even if within normal range 1
• Moderate hematuria with platelet count 50-100 × 10⁹/L

The British guidelines are clear that azathioprine should be promptly reduced or stopped if there is significant bone marrow depression 2. However, isolated hematuria from cystitis without cytopenias does not mandate discontinuation.

Step 3: Treat the Acute Cystitis

First-line antibiotic options (assuming uncomplicated cystitis in a woman):

1. Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days 4

   • Minimal resistance and collateral damage
   • Grade A-I recommendation

2. Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days 4

   • Only if local resistance <20%
   • Grade A-I recommendation

3. Fosfomycin 3 g single dose (alternative) 4

   • Slightly inferior efficacy but acceptable

Avoid fluoroquinolones as first-line due to collateral damage concerns, though they remain highly efficacious alternatives 4.

Important consideration: Patients on azathioprine have immunosuppression, which technically makes this a complicated UTI 5. However, if the patient is otherwise stable without urological abnormalities, standard cystitis treatment is appropriate. Consider extending duration to 7 days rather than 3-5 days given immunosuppression 5.

Step 4: Monitor Response

• Repeat CBC in 1-2 weeks if azathioprine continued 1
• Return to weekly monitoring if dose was adjusted 1
• Assess clinical response to antibiotics within 48-72 hours
• If hematuria persists after treating infection, investigate for other causes (malignancy, stones, etc.)

Critical Pitfalls to Avoid

Do not assume hematuria is always from infection in immunosuppressed patients. Up to 24% of visible hematuria cases may be due to malignancy, and diagnostic evaluation should not be delayed 6.

Do not confuse azathioprine hypersensitivity syndrome with infection or disease flare. This syndrome presents with fever, chills, acute inflammatory response, and sometimes systemic erythema, typically occurring within the first few months of therapy 3. If suspected, immediately discontinue azathioprine and do not rechallenge.

Do not restart azathioprine at full dose after holding for cytopenias. Restart at reduced dose (typically 50% of original) with close monitoring 1.

Do not forget drug interactions: Co-trimoxazole (trimethoprim-sulfamethoxazole) can potentiate azathioprine myelosuppression 1. If using this antibiotic, monitor CBC more closely during and after treatment.

Special Considerations

If the patient has TPMT deficiency (heterozygous), they are already at higher risk for myelosuppression 2, 7. In this scenario, be more aggressive with dose reduction or temporary discontinuation even with mild cytopenias.

For patients requiring urgent cystoscopy or urological intervention due to severe hematuria, azathioprine should be held perioperatively given bleeding risk and infection susceptibility 1.

Resumption of azathioprine after temporary discontinuation should occur once blood counts normalize and infection resolves, typically starting at 50% of the original dose with weekly monitoring for 4 weeks 1.